Caleres (NYSE:CAL) Issues Quarterly Earnings Results

Caleres (NYSE:CAL) released its quarterly earnings results on Thursday. The textile maker reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.01, FiscalAI reports. Caleres had a negative net margin of 0.24% and a positive return on equity of 6.49%. The firm had revenue of $666.60 million during the quarter, compared to analyst estimates of $662.64 million. Caleres updated its Q2 2026 guidance to 0.320-0.380 EPS and its FY 2026 guidance to 1.400-1.650 EPS.

Caleres Stock Down 1.3%

NYSE:CAL opened at $14.19 on Thursday. The company has a fifty day moving average of $12.56 and a 200-day moving average of $12.31. The firm has a market capitalization of $478.77 million, a P/E ratio of -64.50 and a beta of 0.74. Caleres has a twelve month low of $8.80 and a twelve month high of $16.14.

Caleres Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 26th. Stockholders of record on Thursday, June 11th will be paid a $0.07 dividend. The ex-dividend date is Thursday, June 11th. This represents a $0.28 annualized dividend and a dividend yield of 2.0%. Caleres’s payout ratio is currently -127.27%.

Insider Buying and Selling at Caleres

In other news, insider Daniel R. Freidman sold 11,207 shares of Caleres stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $15.00, for a total value of $168,105.00. Following the completion of the sale, the insider owned 64,780 shares in the company, valued at $971,700. The trade was a 14.75% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 3.10% of the stock is owned by corporate insiders.

Institutional Trading of Caleres

Hedge funds have recently modified their holdings of the stock. Osaic Holdings Inc. increased its stake in shares of Caleres by 1,662.8% in the 2nd quarter. Osaic Holdings Inc. now owns 1,992 shares of the textile maker’s stock valued at $25,000 after acquiring an additional 1,879 shares in the last quarter. Global Retirement Partners LLC bought a new stake in shares of Caleres in the 4th quarter valued at $25,000. Quadrant Capital Group LLC increased its stake in shares of Caleres by 1,032.4% in the 4th quarter. Quadrant Capital Group LLC now owns 2,412 shares of the textile maker’s stock valued at $29,000 after acquiring an additional 2,199 shares in the last quarter. Nomura Holdings Inc. bought a new stake in shares of Caleres in the 2nd quarter valued at $136,000. Finally, Entropy Technologies LP bought a new stake in shares of Caleres in the 3rd quarter valued at $150,000. Institutional investors own 98.44% of the company’s stock.

Analyst Ratings Changes

Several research analysts have issued reports on CAL shares. Zacks Research upgraded shares of Caleres from a “hold” rating to a “strong-buy” rating in a report on Thursday, May 21st. Seaport Research Partners lifted their target price on Caleres from $14.00 to $16.00 and gave the stock a “buy” rating in a report on Thursday, March 19th. Finally, Weiss Ratings upgraded Caleres from a “sell (d)” rating to a “sell (d+)” rating in a report on Monday, May 4th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy”.

About Caleres

Caleres, Inc, formerly known as Brown Shoe Company, is a leading footwear company engaged in the design, sourcing, marketing and selling of a broad portfolio of branded and private-label shoes. The company’s operations span a range of market segments from value-priced to premium and luxury. Caleres operates through two primary segments: a retail segment anchored by the Famous Footwear banner, which includes more than 1,100 stores across North America, and a brand portfolio segment comprising owned and licensed brands such as Allen Edmonds, Naturalizer, Sam Edelman, Dr.